Featured Article

MRI in Parkinson's Disease: Expanding Usability for Better Diagnostics

MRI in Parkinson's Disease: Expanding Usability for Better Diagnostics

MRI may be used to identify Parkinson disease biomarkers that can inform diagnosis, track disease progression, and elucidate the neurobiological underpinnings of symptoms.

Latest

β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD

β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD

β-2 adrenergic agonists might be able to fight Parkinson's disease.

Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability

Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability

Patients with postural instability and gait disturbances had worse sleep scores than those with tremor-dominant Parkinson's.

Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence

Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence

Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.

Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease

Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease

Enrollment of patients with only early Parkinson's disease in this trial prevents generalization of the study's findings across the entire Parkinson's population.

Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline

Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline

Patients with both Parkinson's and rapid eye movement sleep behavior disorder were much more likely to experience mild cognitive impairment.

Levodopa-Induced Euphoria May Drive Addictions, Behavior in Parkinson's

Levodopa-Induced Euphoria May Drive Addictions, Behavior in Parkinson's

Patients taking levodopa therapy may experience neuropsychiatric fluctuations characterized by changes in mood, motivation, and anxiety while in ON and OFF states of drug therapy.

Remote Neurological Care a Feasible Option for Parkinson's Disease

Remote Neurological Care a Feasible Option for Parkinson's Disease

For patient's with Parkinson's disease, virtual house calls from neurologists may be of interest.

Patients With Intellectual Disability More Susceptible to Movement Side Effects of Antipsychotics

Patients With Intellectual Disability More Susceptible to Movement Side Effects of Antipsychotics

Incidence of neuroleptic malignant syndrome, akathisia, and parkinsonism was higher in the ID group.

Austedo Wins Second Indication for Tardive Dyskinesia

Austedo Wins Second Indication for Tardive Dyskinesia

Austedo was previously approved for the treatment of chorea in Huntington's disease.

Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease

Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease

In a disease where there have been few therapeutic developments since dopamine, exenatide offers a promising new channel of exploration.

Sign Up for Free e-newsletters